Medicine contacts

Wegovy

Weight-management medicine: NovoCare coverage help, separate home delivery and qualified Medicare GLP-1 Bridge contacts.

Product / program source ↗ · Checked 2026-10-23

Wegovy injection, Wegovy HD and Wegovy tablets have formulation-specific indications and access rules. The current linked charitable-PAP list does not list Wegovy. NovoCare coverage help and self-pay home delivery are separate services. Medicare GLP-1 Bridge contacts follow its current formulation/eligibility rules; no general coverage, savings or IRA price-cap guarantee is inferred.

Medicare GLP-1 Bridge — CMS

patient assistance

Medicare GLP-1 Bridge — beneficiary questions

Official page read
Phone800-633-4227

1-800-MEDICARE for beneficiary Bridge questions and program information.

TTY phone877-486-2048

TTY access to Medicare for beneficiary Bridge information; not an ordinary voice or fax line.

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

Wait time: not establishedBest time from caller reports: not established. Published hours are not a wait forecast.

pharmacy prior auth

Medicare GLP-1 Bridge — prescriber prior-authorization support

Official page read
Phone855-273-0102

Prescriber questions about Bridge prior authorization process or request status.

Published hours

Monday–Friday 08:00–19:00 Eastern.

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

View source ↗ · Source checked 2026-10-23 · Source revision Provider page last modified August 6, 2026.

Report an update
Wait time: not establishedBest time from caller reports: not established. Published hours are not a wait forecast.

fax prior auth

Medicare GLP-1 Bridge — clinician prior-authorization fax

Official page read
Phone

No phone listed for this route

Fax

800-530-2404

Completed Bridge prior-authorization request from the prescribing clinician under the current CMS form.

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

A denied pharmacy claim submitted to the Bridge BIN/PCN is required BEFORE the prescriber submits this request; this is not a requirement for a prior Part D denial. Form submission is restricted to prescribing clinicians. Conditions eligible for regular Part D coverage follow that plan's process. Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

pharmacy help desk

Medicare GLP-1 Bridge — pharmacy claims help desk

Official page read
Phone844-673-0910

Pharmacy questions about Bridge claim submission or submitted-claim status.

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

View source ↗ · Source checked 2026-10-23 · Source revision Pharmacy page last modified August 17, 2026.

Report an update
Wait time: not establishedBest time from caller reports: not established. Published hours are not a wait forecast.

email other

Medicare GLP-1 Bridge — technical program questions only

Official page read
Phone

No phone listed for this route

Published email

glp1demo@cms.hhs.gov

Technical questions about the CMS demonstration; do not include personally identifiable information or protected health information.

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

Not a patient case, prescription, PAP or prior-authorization submission inbox. If secure transfer is necessary, follow CMS instructions to arrange it. Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

View source ↗ · Source checked 2026-10-23 · Source revision Provider page last modified August 6, 2026.

Report an update

Novocare home delivery — Lifefill I, LLC

pharmacy help desk

Novocare home delivery — prescription intake and support

Official page read
Phone866-898-9368

HCP prescription call-in and published home-delivery questions/support. The current FAQ also directs damaged-package recipients to this same number.

Fax

855-251-0222

HCP prescription submission for Novocare home delivery, explicitly published by the current HCP page and corroborated in NPPES. Not a charitable-PAP application fax.

Published hours

Monday–Friday 08:00–21:00 Eastern; Saturday 09:00–17:00 Eastern.

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address
Lifefill I, LLC 1407 Broadway, Room 1910 New York, NY 10018-2874

NPPES registered MAILING address only; registry correspondence location, not a published patient-support, PAP or prescription-intake destination.

Physical address
12639 W Explorer Dr, Ste 125 Boise, ID 83713-1887

Prescribing-system / EHR directory location published with NPI 1225959968 and NCPDP 1311961, corroborated as LOCATION in NPPES. Walk-in service and mailed-prescription intake are not established.

Current official page identifies Lifefill I, LLC d/b/a Novocare and pharmacy services powered by BlinkRx. Separate self-pay home-delivery program for Ozempic and Wegovy; no Rybelsus association, charitable-PAP eligibility, coverage, price, walk-in service or license status inferred. Earlier CoAssist Orlando prescription, case-manager and damaged-delivery proposals are superseded by this current page and are not imported.

View source ↗ · Source checked 2026-10-23 · Source revision US26NC00233, October 2026. Current pharmacy.html redirects to delivery.html. NPPES last updated/certified September 9, 2026. · NPPES Lifefill I, LLC d/b/a NOVOCARE, NPI 1225959968; phone, fax, practice and registered mailing address ↗ · Prior HCP pharmacy URL now redirects to current home-delivery page ↗

Report an update
Wait time: not establishedBest time from caller reports: not established. Published hours are not a wait forecast.

NovoCare medicine access support

patient assistance

Wegovy — coverage-check and access assistance

Official page read
Phone888-809-3942

Representative assistance with the current Wegovy coverage-check tool and access questions.

Published hours

Monday–Friday 08:00-20:00 Eastern, as published on this product page.

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

No coverage form was filled out. No bridge-program eligibility, coverage, quoted price or Medicare negotiated-price value is inferred.

View source ↗ · Source checked 2026-10-23

Report an update
Wait time: not establishedBest time from caller reports: not established. Published hours are not a wait forecast.

For healthcare offices

Found the contact. Still need to make the call?

Explore how DialClerk organizes the brief, hold time and staff handoff for your next administrative call.

For the people making the calls

Put payer follow-up
on your office’s worklist.

Explore DialClerk for queued calls, hold handling, staff handoffs and a record of the next step. Tell us how your team works.

A request does not create an account or start a call. Use business contact information only. No patient information.

See how it could work for your practice